PSO 2023 HRO AND Safety Education Series: Conducting an effective cause analysis

June 20, 2023

Attendees will gain knowledge on leading practices for triaging events and prioritizing events for improvement, when to conduct RCAs and other types of analyses (common cause, apparent cause, PDSA, etc.), how to disseminate learnings and action plans, and monitor compliance to action plans and improvement. 

Target Audience

  • Nurses
  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:
 
  1. Discuss the process organizations use to prioritize their events for improvement and determine if further analysis in needed.
  2. Discuss how organizations select the type of cause analysis to conduct.
  3. Describe the process for disseminating learnings and action plans across an organization or health system.
  4. Describe how organizations develop, monitor, and oversee action plans to ensure their effectiveness and sustained improvement.

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.81 KB
File 06-20-2023 - CE Information.docx118.9 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Course opens: 
06/14/2023
Course expires: 
08/04/2023
Event starts: 
06/20/2023 - 1:00pm CDT
Event ends: 
06/20/2023 - 2:00pm CDT
Add to calendar: 
Live activity
United States
Faculty & Planners
Planning Committee 
Ellen Flynn, RN, MBA, JD, CPPS (Course Director)    
Principal, Vizient Inc.
 
Tammy Williams, MSN, RN, CPPS
Program Director, Vizient Inc.
 
Kathryn Merkeley   MHSA, RN, PMP, CPPS
Program Director, Vizient Inc.
 
Christina Driskill, MPH, RN, CPHQ
Program Director, Vizient Inc.
 
Jay Prystowski, MD, MBA
Principal, Vizient Inc.
 
James Lichauer, Pharm.D., BCPS, FASHP
PI Program Director, Vizient Inc.
 
Faculty

Benjamin Wertheimer, MD
Patient Safety Officer, Assistant Professor in Medicine, Hospitalist
NYU Langone Health

Elizabeth Haines, DO, MSc
Service Chief of Quality- Hassenfeld Children’s Hospital
NYU Langone Health

Mbonu Ikezuagu, MD, FACP, CPE
Vice President & Chief Quality Officer
ThedaCare

Tami Flemmer, MSN, RN, CPHRM
Senior Director Risk Management
Bismarck
Sanford Health

A. Joy Rivera, PhD
Human Factors Engineer, 
Executive Director, Patient Safety & Patient Relations 
Froedtert Health 

Markan-Aurora, Sumita, MD
System Director, Patient Safety and Clinical Outcomes
SSM Health 

Craig Clapper, PE
Executive advisor
SSM Health 
 

 

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Disclosure of Financial Relationships
 
Absence of Relevant Financial Relationships
 
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
  • No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
 

Statement of Content Validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Credit Designation Statement(s)

Nurses (CNE)
This activity is designated for 1.00 contact hours.
 
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours.
 
Pharmacists (CPE)
Vizient, Inc. designates this activity for a maximum of for 1.00 contact hour(s) for all pharmacists.
 
Universal Activity Number: JA0006103-0000-23-068-L05-P
 
Physicians (CME)
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Please login or register to take this course.

Select the Obtain Credit button to access the session evaluation and to claim CE Credit.